Effect of EGFR Mutations on Survival in Patients following Surgical Resection of Lung Adenocarcinoma

被引：0
|
作者：
Laidlaw, Grace [1 ]
Gao, Rebecca [1 ]
Ayers, Kelsey [2 ]
Backhus, Leah [2 ]
Berry, Mark [2 ]
Shrager, Joseph [2 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Cardiothorac Surg, Stanford, CA 94305 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
EGFR; lung adenocarcinoma; sublobar resection;
D O I：
10.1016/j.jtho.2016.11.1000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.08-033
引用
收藏
页码：S751 / S751
页数：1
相关论文
共 50 条
  • [1] EGFR Amplification and Sensitizing Mutations Correlates with Survival from Erlotinib in Lung Adenocarcinoma Patients
    Ruiz-Patino, A.
    Castro, C.
    Ricaurte, L.
    Cardona, A.
    Rojas, L.
    Zatarain-Barron, Z.
    Wills, B.
    Reguart, N.
    Carranza, H.
    Vargas, C.
    Otero, J.
    Corrales, L.
    Martin, C.
    Archila, P.
    Rodriguez, J.
    Avila, J.
    Bravo, M.
    Pino, L.
    Rosell, R.
    Arrieta, O.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S161 - S162
  • [2] Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
    Luka Brcic
    Marko Jakopovic
    Marija Misic
    Fran Seiwerth
    Izidor Kern
    Silvana Smojver-Jezek
    Franz Quehenberger
    Miroslav Samarzija
    Sven Seiwerth
    Diagnostic Pathology, 11
  • [3] Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
    Brcic, Luka
    Jakopovic, Marko
    Misic, Marija
    Seiwerth, Fran
    Kern, Izidor
    Smojver-Jezek, Silvana
    Quehenberger, Franz
    Samarzija, Miroslav
    Seiwerth, Sven
    DIAGNOSTIC PATHOLOGY, 2016, 11 : 1
  • [4] Clinicopathological characteristics of lung adenocarcinoma with compound EGFR mutations
    Hayashi, Takuo
    Kohsaka, Shinji
    Takamochi, Kazuya
    Hara, Kieko
    Kishikawa, Satsuki
    Sano, Kei
    Takahashi, Fumiyuki
    Suehara, Yoshiyuki
    Saito, Tsuyoshi
    Takahashi, Kazuhisa
    Suzuki, Kenji
    Yao, Takashi
    HUMAN PATHOLOGY, 2020, 103 : 42 - 51
  • [5] Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib
    Zhang, Li
    Yuan, Xianglin
    Chen, Yuan
    Du, Xiao-Juan
    Yu, Shiying
    Yang, Ming
    GENE, 2013, 517 (01) : 60 - 64
  • [6] Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma
    Hofman, P.
    Ilie, M.
    Hofman, V.
    Roux, S.
    Valent, A.
    Bernheim, A.
    Alifano, M.
    Leroy-Ladurie, F.
    Vaylet, F.
    Rouquette, I.
    Validire, P.
    Beau-Faller, M.
    Lacroix, L.
    Soria, J. C.
    Fouret, P.
    ANNALS OF ONCOLOGY, 2012, 23 (07) : 1738 - 1743
  • [7] HER-2 Mutations in Chinese Lung Adenocarcinoma Patients with Negative EGFR Mutations
    Zhou, Caicun
    Li, Xuefei
    Zhao, Chao
    Ren, Shengxiang
    Su, Chunxia
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S705 - S705
  • [8] Clinical Features and Progression Free Survival of Lung Adenocarcinoma Patients with EGFR sensitizing mutations with Dose Reduction of Afatinib
    Angasreni, W.
    Andarini, S. L.
    Zaini, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S641 - S642
  • [9] KRAS and EGFR mutations coexisting in lung adenocarcinoma
    Vitor Sousa
    Ana Alarcão
    Patricia Couceiro
    Maria R Silva
    Maria J d’Aguiar
    Lia Teixeira
    Lina Carvalho
    BMC Proceedings, 4 (Suppl 2)
  • [10] Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients
    Shan, Ling
    Wang, Ziping
    Guo, Lei
    Sun, Hongyan
    Qiu, Tian
    Ling, Yun
    Li, Wenbin
    Li, Lin
    Liu, Xiuyun
    Zheng, Bo
    Lu, Ning
    Ying, Jianming
    LUNG CANCER, 2015, 89 (03) : 337 - 342
12345